Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia

Therapy of acute myeloid leukemia in older persons is associated with poor outcomes because of intolerance to intensive therapy, resistant disease and co-morbidities. This multi-center, randomized, open-label, phase II trial compared safety and efficacy of three therapeutic strategies in patients 65...

Descripción completa

Detalles Bibliográficos
Autores principales: Medeiros, Bruno C., McCaul, Kelly, Kambhampati, Suman, Pollyea, Daniel A., Kumar, Rajat, Silverman, Lewis R., Kew, Andrea, Saini, Lalit, Beach, CL, Vij, Ravi, Wang, Xiwei, Zhong, Jim, Gale, Robert Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777197/
https://www.ncbi.nlm.nih.gov/pubmed/29097499
http://dx.doi.org/10.3324/haematol.2017.172353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777197/
https://www.ncbi.nlm.nih.gov/pubmed/29097499
http://dx.doi.org/10.3324/haematol.2017.172353

Ejemplares similares